DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Noble Capital Reinstates Outperform on TrovaGene

Noble Capital analyst Cosme Ordonez reinstates TrovaGene (NASDAQ:TROV) with a Outperform.

Benzinga · 01/28/2020 15:46

Noble Capital analyst Cosme Ordonez reinstates TrovaGene (NASDAQ:TROV) with a Outperform.